Hurley Capital’s Omnicell OMCL Stock Holding History

Hurley Capital’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-400	Closed	-$11.8K	–	699
2025 Q2	$11.8K	Sell	400 -100	-20%	-$2.99K	0.01%	293
2025 Q1	$17.5K	Buy	+500	New	+$19.8K	0.01%	268

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hurley Capital's OMCL Position: Q3 2025 in Review

Hurley Capital sold out of Omnicell (OMCL) in Q3 2025, closing a stake of 400 shares — an estimated $11.8K sold.

Hurley Capital first reported a position in OMCL in Q1 2025 and held it in 2 quarters. The position peaked at $17.5K in Q1 2025. 259 funds tracked by Wall St. Rank hold OMCL as of Q3 2025.

Hurley Capital reported no remaining Omnicell position as of Q3 2025 after selling out during the quarter.
Hurley Capital sold 400 Omnicell shares in Q3 2025, an estimated $11.8K.
Hurley Capital first reported a position in Omnicell in Q1 2025 and held it in 2 quarters.
Hurley Capital's Omnicell position peaked at $17.5K in Q1 2025.
259 funds tracked by Wall St. Rank held Omnicell as of Q3 2025.

Based on Hurley Capital's 13F filing for Q3 2025, filed 12 Nov 2025.